Wolverine Trading
CRBP icon

Wolverine Trading’s Corbus Pharmaceuticals CRBP Stock Holding History

Wolverine Trading’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-587
Closed -$9K – 4653
2022
Q1 		$9K Sell
587
-90
-13% -$1.19K ﹤0.01% 5300
2021
Q4 		$12K Sell
677
-413
-38% -$11.2K ﹤0.01% 5535
2021
Q3 		$33K Buy
1,090
+340
+45% +$13.4K ﹤0.01% 6081
2021
Q2 		$41K Buy
750
+230
+44% +$12.8K ﹤0.01% 5634
2021
Q1 		$29K Sell
520
-43
-8% -$2.83K ﹤0.01% 5728
2020
Q4 		$22K Sell
563
-1,740
-76% -$65.1K ﹤0.01% 4693
2020
Q3 		$136K Buy
2,303
+880
+62% +$159K ﹤0.01% 4017
2020
Q2 		$338K Buy
1,423
+1,063
+295% +$215K ﹤0.01% 3176
2020
Q1 		$60K Sell
360
-403
-53% -$68.1K ﹤0.01% 4199
2019
Q4 		$123K Sell
763
-360
-32% -$53.2K ﹤0.01% 4223
2019
Q3 		$169K Sell
1,123
-730
-39% -$127K ﹤0.01% 3662
2019
Q2 		$385K Buy
1,853
+190
+11% +$40.7K ﹤0.01% 3001
2019
Q1 		$347K Buy
1,663
+350
+27% +$77.2K ﹤0.01% 3191
2018
Q4 		$232K Buy
1,313
+413
+46% +$82.4K ﹤0.01% 3529
2018
Q3 		$204K Buy
900
+177
+24% +$28.6K ﹤0.01% 4244
2018
Q2 		$132K Hold
723
– – ﹤0.01% 4613
2018
Q1 		$132K Sell
723
-384
-35% -$86.2K ﹤0.01% 4613
2017
Q4 		$236K Buy
+1,107
New +$237K ﹤0.01% 3930
2017
Q3 		– Sell
-1,033
Closed -$194K – 4490
2017
Q2 		$194K Buy
+1,033
New +$203K ﹤0.01% 3615

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's CRBP Position: Q2 2022 in Review

Wolverine Trading sold out of Corbus Pharmaceuticals (CRBP) in Q2 2022, closing a stake of 613 shares — an estimated $5.92K sold.

Wolverine Trading first reported a position in CRBP in Q2 2017 and held it in 14 quarters. The position peaked at $201K in Q4 2018. 70 funds tracked by Wall St. Rank hold CRBP as of Q2 2022.

  • Wolverine Trading reported no remaining Corbus Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Wolverine Trading sold 613 Corbus Pharmaceuticals shares in Q2 2022, an estimated $5.92K.
  • Wolverine Trading first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 14 quarters.
  • Wolverine Trading's Corbus Pharmaceuticals position peaked at $201K in Q4 2018.
  • 70 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.